Health Benefits of Nonsugar Sweeteners Uncertain
However, large systematic review could not rule out harms from nonsugar sweeteners
December 2018 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2018. This roundup includes...
No Increased Fracture Risk With Canagliflozin in Type 2 Diabetes
Rate of the primary outcome was similar for canagliflozin, glucagon-like peptide-1 agonist
Three Novel Loci Associated With Polycystic Ovary Syndrome ID’d
Genetic links with obesity, T2DM, lipids suggest shared genetic architecture for PCOS, metabolic traits
Incidence of End-Stage Kidney Disease Up in Australia
Incidence increased for nonindigenous people with type 2 diabetes; greatest increase for under 50s, over 80s
Pregnancy Complications Up for Women Born at Low Birth Weight
Risk greatest for women born with birth weight <2,500 g who develop overweight/obesity
Sugar-Sweetened Drinks Linked to Chronic Kidney Disease Risk
Odds of CKD up with beverage pattern consisting of higher intake of sweetened soda, fruit drinks, water
Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
Cardiovascular risk increased with sulfonylureas and basal insulin versus newer classes of ADM
Low-Priced Generic Drugs Most Likely to Have Shortages
Shortages associated with modest increases in price, ranging from 6 to 14 percent
Targeted Muscle Reinnervation Can Reduce Phantom Limb Pain
Authors report reduction in pain and no symptomatic neuromas in 22 below-the-knee amputees
